|Posted by firstname.lastname@example.org on April 23, 2019 at 3:45 PM||comments (0)|
BRCA1 is a tumour suppression gene that is responsible for DNA repair. However it has been found to have low expression in breast cancer.
As such this gene is an excellent potential bio-marker for detecting breast cancer in patients. As such if Snapshot detects low expression in BRCA1 it will be highlighted in the disease table as low expression can increase chances of breast cancer.
Learn more about BRCA1 here:Read Full Post »
|Posted by mswayne on January 3, 2019 at 5:10 AM||comments (0)|
Scarborough Biotechnology has officially become Scarborough Technologies, representing growth into new industries, including fintech and quantum computing, according to the company’s founder and director.
“Improving the health and lives of people will remain at the core of our company’s mission and the recent discovery that our technology and intellectual property has implications across industries only broadens that commitment,” said Macauley Coggins, director o...Read Full Post »
|Posted by mswayne on December 2, 2018 at 7:45 AM||comments (0)|
Biotechnology terms, such as CRISPR, genome edits and GMOs, are making their way out of the labs and into everyday lives, proving that genetic engineering is now an undeniable force that will shape everything from what people eat to how long they live. Scarborough Biotechnology, a biotechnology company that is creating tools to master the genome, is offering a genetic engineering guide for students, business owners, and just people wondering how this technology will change the world, accordin...Read Full Post »
|Posted by mswayne on November 14, 2018 at 5:25 AM||comments (0)|
The healthcare, pharmaceutical, and medical industries are investing heavily in cutting-edge software solutions and smarter machine learning and artificial intelligence technology. The full benefits of this tech revolution may lead to a revolution in disease treatment and extend the healthspan of millions of patients, according to those experts.
According to recent statistics, information technology budgets are increasing across the country, but experts say the healthcare IT spending, ...Read Full Post »
|Posted by mswayne on October 30, 2018 at 5:00 PM||comments (0)|
Visualizing data is an important part of understanding the data.
In the latest version of Snapshot, scientists can now see visual representations of gene expressions through the visual analytics function, said Macauley Coggins, director of Scarborough Biotechnology. Snapshot is the company’s premier software solution that allows genome-scale model of human metabolism.
“We think that building this visualization feature will make studying g...Read Full Post »
|Posted by mswayne on October 3, 2018 at 7:20 AM||comments (0)|
When you think genetic engineering, you tend to think of large companies and well-funded research laboratories. But, with breakthroughs such as CRISPR becoming more common, smaller companies and teams now have the same access to the power of genetic engineering that once was only in the hands of these labs and big companies.
However, genetic engineering tools and equipment is still expensive. But, that was before the disruptive power of Snapshot came along.
Scarborough ...Read Full Post »
|Posted by email@example.com on September 24, 2018 at 5:35 AM||comments (0)|
|Posted by firstname.lastname@example.org on September 3, 2018 at 4:25 AM||comments (0)|
Update 1.3.0 is probably the largest update to come to Snapshot so far by adding 18 genes, 8 reactions, and 14 metabolites as well as a host of improvements to metabolite prediction.
|Posted by email@example.com on July 24, 2018 at 10:10 AM||comments (0)|
According to Genetic Disorders UK.org there are between 4,000 to 6,000 diagnosed genetic disorders ranging from common disorders such as sickle cell disease (1 in 500 africans) to more rare disorders such as lactate dehydrogenase A deficiency which has a prevelance of only 1 in 1 milion. Given the amount of potential disorders there is a push for more rapid yet accurate diagnosis for patients.... Read Full Post »
|Posted by firstname.lastname@example.org on July 16, 2018 at 10:55 AM||comments (0)|
With new cutting edge pharmaceuticals relying heavily on recombinant proteins there has been a big push by bioprocessing companies to optimise and increase production of recombinant proteins. These proteins are typically produced in bacterial cells such as e-coli and for more complex proteins mamalian cell lines such as CHO.
However growing proteins in mamalian cells like CHO is challenging as they require optimal en...Read Full Post »